title: Improving clinical outcomes with pembrolizumab in patients with advanced melanoma.
authors.affiliation: Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
authors.forename: Dae Won
authors.initials: DW
authors.lastname: Kim
authors.affiliation: Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA.
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Zager
authors.affiliation: Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, Florida, USA. Zeynep.Eroglu@moffitt.org.
authors.forename: Zeynep
authors.initials: Z
authors.lastname: Eroglu
mesh_terms: D061067:Antibodies, Monoclonal, Humanized; D006801:Humans; D008545:Melanoma
chemical_list: D061067:Antibodies, Monoclonal, Humanized; C582435:pembrolizumab